# The Real-world Study of Rimegepant Treatment in Female Migraine Patients of China

> **NCT06728345** · — · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 300 (estimated)

## Conditions studied

- Migraine
- Migraine Prophylaxis

## Interventions

- **DRUG:** Rimegepant

## Key facts

- **NCT ID:** NCT06728345
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06728345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06728345, "The Real-world Study of Rimegepant Treatment in Female Migraine Patients of China". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06728345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*